دورية أكاديمية
Critical assessment of resource waste in staging and follow-up of breast cancer.
| العنوان: | Critical assessment of resource waste in staging and follow-up of breast cancer. |
|---|---|
| المؤلفون: | Bonometto JVB; Centro Universitário Faculdade de Medicina do ABC, Department of Oncology - Santo André (SP), Brazil., Sette CVM; Centro Universitário Faculdade de Medicina do ABC, Department of Oncology - Santo André (SP), Brazil., Santi PX; Centro Universitário Faculdade de Medicina do ABC, Department of Oncology - Santo André (SP), Brazil., Maselli-Schoueri JH; Centro Universitário Faculdade de Medicina do ABC, Department of Oncology - Santo André (SP), Brazil., Giglio AD; Centro Universitário Faculdade de Medicina do ABC, Department of Oncology - Santo André (SP), Brazil., Cubero DIG; Centro Universitário Faculdade de Medicina do ABC, Department of Oncology - Santo André (SP), Brazil. |
| المصدر: | Revista da Associacao Medica Brasileira (1992) [Rev Assoc Med Bras (1992)] 2023 Nov 24; Vol. 69 (12), pp. e20230565. Date of Electronic Publication: 2023 Nov 24 (Print Publication: 2023). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Associação Médica Brasileira Country of Publication: Brazil NLM ID: 9308586 Publication Model: eCollection Cited Medium: Internet ISSN: 1806-9282 (Electronic) Linking ISSN: 01044230 NLM ISO Abbreviation: Rev Assoc Med Bras (1992) Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: São Paulo : Associação Médica Brasileira |
| مواضيع طبية MeSH: | Breast Neoplasms*/therapy , Breast Neoplasms*/pathology, Humans ; Female ; Follow-Up Studies ; Retrospective Studies ; Physical Examination ; Brazil ; Neoplasm Staging |
| مستخلص: | Background: Breast cancer is a public health problem with both high incidence and cure rates. After treatment, patients are monitored for long periods of time due to the risk of recurrence. Thus, staging and follow-up strategies should consider not only the best results for the patient but also its costs for the public health system. Objective: The objective of this study was to quantify the waste of resources on breast cancer follow-up and evaluate its impact on the public health system. Methods: This is a retrospective analysis of consecutive medical records to identify the intervals between consultations and tests used for staging and during the first 2 years of follow-up of patients with breast cancer treated at a public hospital in Brazil. Data were compared with the guidelines of the main international consensus. Results: Medical records of 60 consecutive patients treated in 2018 were selected, of whom 52 had 2 or more years of follow-up, and 8 had only 1 year of complete follow-up. A total of 34 patients (56.67%) underwent excessive examinations for stating. During follow-up, 125 surplus consultations were performed (33.6%). In this phase, 111 surplus exams were also performed, representing an increase of 100.9%. A total of 423 laboratory tests were performed for 18 patients in the first year and 229 tests for 14 patients in the second year. Conclusion: Excessive tests and consultations significantly burdened the Unified Health System without any benefit to patients. Better adherence to staging and follow-up recommendations could reduce costs and optimize the limited resources used in the public health system. |
| References: | Curr Oncol. 2021 Jun 12;28(3):2190-2198. (PMID: 34204717) Asian Pac J Cancer Prev. 2019 Jun 01;20(6):1857-1864. (PMID: 31244310) Ann Intern Med. 2016 Feb 16;164(4):205-14. (PMID: 26756460) Rev Bras Ginecol Obstet. 2019 Nov;41(11):633-635. (PMID: 31745955) J Clin Oncol. 2012 May 10;30(14):1715-24. (PMID: 22493340) J Natl Compr Canc Netw. 2022 Jun;20(6):691-722. (PMID: 35714673) Breast. 2020 Dec;54:272-277. (PMID: 33242753) J Clin Oncol. 2020 Feb 1;38(4):332-350. (PMID: 31804858) JAMA. 2012 Apr 4;307(13):1394-404. (PMID: 22474203) J Clin Oncol. 2013 Mar 1;31(7):961-5. (PMID: 23129741) J Natl Compr Canc Netw. 2017 Jun;15(6):783-789. (PMID: 28596258) Oncologist. 2016 Dec;21(12):1495-1501. (PMID: 27551013) Ann Oncol. 2019 Aug 1;30(8):1194-1220. (PMID: 31161190) |
| تواريخ الأحداث: | Date Created: 20231206 Date Completed: 20231211 Latest Revision: 20231211 |
| رمز التحديث: | 20240829 |
| مُعرف محوري في PubMed: | PMC10691367 |
| DOI: | 10.1590/1806-9282.20230565 |
| PMID: | 38055451 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1806-9282 |
|---|---|
| DOI: | 10.1590/1806-9282.20230565 |